-
-
Erectile Dysfunction and Subsequent Cardiovascular Disease; Oseltamivir Resistance during Influenza A Infection; Dietary Intake of Antioxidants and AMD
-
The FDA has approved a new drug for the treatment of gastrointestinal stromal tumor and metastatic renal cell cancer. Sunitinib is an orally active, highly selective, multi-targeted tyrosine kinase inhibitor. The drug was given a priority review and was approved in less than 6 months. Sunitinib is marketed by Pfizer as Sutent®.
-
Participants in the Framingham Heart Study who had low levels of cardiovascular risk factors in middle age had longer overall survival and less morbidity when followed to age 85. Control of risk factors may have a major influence on reaching older age in good health.
-
The use of a laxative, a digestive aid, and a surfactant leads to speedier recovery from partial small bowel obstruction with less need for surgery.
-
In the largest randomized dietary intervention trial conducted to date, a low-fat predominately carbohydrate diet resulted weight maintenance over 7.5 years in postmenopausal women compared with a control diet higher in fat.
-
Rosiglitazone improves exercise capacity in individuals with Type 2 Diabetes.
-
-
Treating Opioid-Dependent Patients with OAT; Long-Term Effects of Warfarin Use; Statins Multiple Benefits; FDA Actions
-
The ECG in the Figure was obtained from a 70-year-old woman in heart failure. There are at least 6 findings that we feel are worthy of mention. Can you identify them? Clinically, what is your concern?